D
Ardelyx, Inc. ARDX
$6.07 $1.0621.11% NASDAQ
Recommendation
Prev Close
$5.01
Volume
14,620,783
Avg Vol (90D)
3,791,436
Market Cap
$1.21B
Dividend & Yield
--
52-Week Range
$3.21 - $6.78
P/E (TTM)
--
EPS (TTM)
-$0.24
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Ardelyx price target raised by $1 at TD Cowen, here's why
10/31/2025 - The Fly
Ardelyx Shares Soar Premarket As CEO Sees Continued Demand For Blockbuster Drug Ibsrela
10/31/2025 - Stocktwits News Feed
Ardelyx (ARDX) Reports Strong Q3 Growth, Raises Full-Year Guidance
10/31/2025 - GuruFocus
Decoding Ardelyx Inc (ARDX): A Strategic SWOT Insight
10/31/2025 - GuruFocus
Ardelyx raises 2025 IBSRELA revenue guidance to $270M-$275M as growth accelerates
10/31/2025 - SeekingAlpha.com: All News
Ardelyx, Inc. (ARDX) Q3 2025 Earnings Call Transcript
10/31/2025 - Seeking Alpha: Transcripts
Ardelyx, Inc. (ARDX) Q3 2025 Earnings Call Transcript
10/31/2025 - SeekingAlpha
Ardelyx Inc (ARDX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges
10/31/2025 - GuruFocus
Q3 2025 Ardelyx Inc Earnings Call Transcript
10/31/2025 - GuruFocus
Ardelyx (ARDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
10/30/2025 - Zacks Investment Research
Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
10/30/2025 - GuruFocus
Ardelyx (ARDX) Reports Break-Even Earnings for Q3
10/30/2025 - Zacks Investment Research
Ardelyx reports Q3 EPS 0c, consensus (7c)
10/30/2025 - The Fly
Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
10/30/2025 - Globe Newswire
How Real-World IBSRELA Data at Ardelyx (ARDX) May Shift the Investment Narrative
10/30/2025 - Simply Wall St
Assessing Ardelyx (ARDX) Valuation Following Recent Share Price Fluctuations
10/28/2025 - Simply Wall St
Ardelyx (ARDX) Showcases New Data on IBSRELA at ACG Meeting
10/28/2025 - GuruFocus
Ardelyx presents data on IBSRELA at ACG annual scientific meeting
10/28/2025 - TipRanks Financial Blog
Ardelyx presents data on IBSRELA at ACG annual scientific meeting
10/28/2025 - The Fly
Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA (tenapanor) at the American College of Gastroenterology's 2025 Annual Meeting
10/28/2025 - Globe Newswire
Ardelyx Inc.'s Pediatric IBS-C Study: A Potential Game-Changer for the Market
10/27/2025 - TipRanks Financial Blog
Ardelyx management to meet virtually with BTIG
10/27/2025 - TipRanks Financial Blog
Ardelyx management to meet virtually with BTIG
10/27/2025 - The Fly
Ardelyx (NASDAQ:ARDX) Given "Sell (D-)" Rating at Weiss Ratings
10/25/2025 - MarketBeat
Cantor Fitzgerald Raises Earnings Estimates for Ardelyx
10/24/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$386.15M
EBITDA (TTM)
-$38.09M
EBIT (TTM)
-$40.39M
Net Income (TTM)
-$56.39M
Balance Sheet
Total Assets (Q)
$466.77M
Total Debt (Q)
$234.40M
Total Liabilities (Q)
$327.24M
Book Value Per Share (Q)
$0.5795
Cash Flow
Cash from Operations (TTM)
-$53.49M
Cash from Investing (TTM)
-$1.51M
Cash from Financing (TTM)
$103.15M
Net Change in Cash (TTM)
$48.16M
Filings
Filing Date
Monday, August 4, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Oct 27 and 31 (est)
Price History
Loading...
Beta
0.53
7-Day Total Return
17.77%
30-Day Total Return
-2.34%
60-Day Total Return
18.00%
90-Day Total Return
67.08%
Year to Date Total Return
18.46%
1-Year Total Return
3.32%
2-Year Total Return
53.54%
3-Year Total Return
304.33%
5-Year Total Return
16.86%
52-week Low
May 15, 2025 - $3.21
52-week High
Sep 11, 2025 - $6.78
Valuation
Market Cap
$1.21B - Small Cap
Enterprise Value
$1.20B
Price/Sales (TTM)
3.11
Price/Book (Q)
8.65
Dividends and Shares
Shares Outstanding
239.93
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.ardelyx.com
Phone Number
510 745 1700
Address
400 Fifth Avenue
Waltham, MA 02451
Country
United States
Year Founded
2007
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small... more
NASDAQ 10/31/2025 1:44PM Eastern Quotes delayed